(NK) Imerys - Overview
Stock: Performance Minerals, Specialty Minerals, Graphite, Carbon, Industrial Additives
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.88% |
| Yield on Cost 5y | 4.64% |
| Yield CAGR 5y | 5.97% |
| Payout Consistency | 94.1% |
| Payout Ratio | 1.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.0% |
| Relative Tail Risk | -12.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -4.67 |
| Character TTM | |
|---|---|
| Beta | 0.191 |
| Beta Downside | 0.237 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.77% |
| CAGR/Max DD | -0.18 |
Description: NK Imerys January 16, 2026
Imerys S.A. (ticker NK) is a global supplier of specialty minerals, offering performance additives for plastics, paints, coatings, filtration, life-sciences, ceramics and building products, as well as processing aids for refractory, foundry, abrasives and construction chemistry, plus graphite and carbon minerals targeting the energy-transition and mobile-energy markets. Its product portfolio spans andalusite, bentonite, calcium carbonate, carbon black, diatomite, graphite, lithium, mullite, perlite, quartz, talc, zeolite, zirconia and wollastonite, serving end-markets from batteries and fuel cells to cosmetics, food & beverage, infrastructure and rubber.
In FY 2023 Imerys generated roughly €4.5 billion in revenue, with an adjusted EBITDA margin of about 10 %, and reported a 15 % year-on-year increase in sales of battery-related minerals (lithium, graphite, and carbon black). The company’s growth is closely tied to two macro-drivers: (1) the accelerating demand for electric-vehicle batteries, which is projected to raise global lithium and graphite consumption by 20 %–30 % over the next five years, and (2) sustained construction activity in emerging markets, supporting its traditional building-materials segment.
For a deeper quantitative assessment, you may find the ValueRay platform’s detailed metric breakdown useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -143.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.60 > 1.0 |
| NWC/Revenue: 17.82% < 20% (prev 30.62%; Δ -12.80% < -1%) |
| CFO/TA 0.06 > 3% & CFO 390.9m > Net Income -143.5m |
| Net Debt (1.42b) to EBITDA (393.0m): 3.61 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.9m) vs 12m ago 1.63% < -2% |
| Gross Margin: 58.76% > 18% (prev 0.24%; Δ 5852 % > 0.5%) |
| Asset Turnover: 76.32% > 50% (prev 51.91%; Δ 24.41% > 0%) |
| Interest Coverage Ratio: -0.22 > 6 (EBITDA TTM 393.0m / Interest Expense TTM 94.7m) |
Altman Z'' 1.79
| A: 0.14 (Total Current Assets 1.80b - Total Current Liabilities 875.1m) / Total Assets 6.36b |
| B: 0.01 (Retained Earnings 70.5m / Total Assets 6.36b) |
| C: -0.00 (EBIT TTM -21.3m / Avg Total Assets 6.77b) |
| D: 0.79 (Book Value of Equity 2.56b / Total Liabilities 3.25b) |
| Altman-Z'' Score: 1.79 = BBB |
Beneish M -3.46
| DSRI: 0.72 (Receivables 595.1m/594.5m, Revenue 5.17b/3.73b) |
| GMI: 0.41 (GM 58.76% / 23.93%) |
| AQI: 1.24 (AQ_t 0.46 / AQ_t-1 0.38) |
| SGI: 1.39 (Revenue 5.17b / 3.73b) |
| TATA: -0.08 (NI -143.5m - CFO 390.9m) / TA 6.36b) |
| Beneish M-Score: -3.46 (Cap -4..+1) = AA |
What is the price of NK shares?
Over the past week, the price has changed by +3.89%, over one month by +11.72%, over three months by +28.95% and over the past year by +4.45%.
Is NK a buy, sell or hold?
What are the forecasts/targets for the NK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.2 | -0.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30.4 | 11.7% |
NK Fundamental Data Overview February 03, 2026
P/S = 0.6485
P/B = 0.7234
P/EG = 2.22
Revenue TTM = 5.17b EUR
EBIT TTM = -21.3m EUR
EBITDA TTM = 393.0m EUR
Long Term Debt = 1.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 85.7m EUR (from shortTermDebt, last quarter)
Debt = 1.89b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b EUR (from netDebt column, last quarter)
Enterprise Value = 3.63b EUR (2.21b + Debt 1.89b - CCE 477.8m)
Interest Coverage Ratio = -0.22 (Ebit TTM -21.3m / Interest Expense TTM 94.7m)
EV/FCF = 32.15x (Enterprise Value 3.63b / FCF TTM 112.8m)
FCF Yield = 3.11% (FCF TTM 112.8m / Enterprise Value 3.63b)
FCF Margin = 2.18% (FCF TTM 112.8m / Revenue TTM 5.17b)
Net Margin = -2.78% (Net Income TTM -143.5m / Revenue TTM 5.17b)
Gross Margin = 58.76% ((Revenue TTM 5.17b - Cost of Revenue TTM 2.13b) / Revenue TTM)
Gross Margin QoQ = 27.28% (prev none%)
Tobins Q-Ratio = 0.57 (Enterprise Value 3.63b / Total Assets 6.36b)
Interest Expense / Debt = 1.85% (Interest Expense 34.9m / Debt 1.89b)
Taxrate = 27.62% (26.9m / 97.4m)
NOPAT = -15.4m (EBIT -21.3m * (1 - 27.62%)) [loss with tax shield]
Current Ratio = 2.05 (Total Current Assets 1.80b / Total Current Liabilities 875.1m)
Debt / Equity = 0.61 (Debt 1.89b / totalStockholderEquity, last quarter 3.09b)
Debt / EBITDA = 3.61 (Net Debt 1.42b / EBITDA 393.0m)
Debt / FCF = 12.58 (Net Debt 1.42b / FCF TTM 112.8m)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.12% (Net Income -143.5m / Total Assets 6.36b)
RoE = -4.45% (Net Income TTM -143.5m / Total Stockholder Equity 3.22b)
RoCE = -0.43% (EBIT -21.3m / Capital Employed (Equity 3.22b + L.T.Debt 1.70b))
RoIC = -0.31% (negative operating profit) (NOPAT -15.4m / Invested Capital 4.93b)
WACC = 4.19% (E(2.21b)/V(4.10b) * Re(6.62%) + D(1.89b)/V(4.10b) * Rd(1.85%) * (1-Tc(0.28)))
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.86%
[DCF Debug] Terminal Value 87.08% ; FCFF base≈135.8m ; Y1≈146.9m ; Y5≈182.1m
Fair Price DCF = 47.00 (EV 5.38b - Net Debt 1.42b = Equity 3.97b / Shares 84.4m; r=5.90% [WACC]; 5y FCF grow 9.28% → 2.90% )
EPS Correlation: -29.12 | EPS CAGR: -17.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 3.40 | Revenue CAGR: 13.18% | SUE: 2.06 | # QB: 1
EPS next Year (2026-12-31): EPS=2.07 | Chg30d=-0.125 | Revisions Net=-1 | Growth EPS=+17.8% | Growth Revenue=+3.5%